4,681 karma · joined February 9, 2011
This and/or making loans dischargeable in bankruptcy.
Even given that, this is their second try (they had Spark 1.0). Spark 1.0 was uninteresting, this is potentially interesting, but we can't really try it yet it seems (at least not in Openrouter).
Ultimately, competition is now fierce in this broad level of intelligence/cost: Spark 1.1, Grok 4.5, GPT 5.6 Luna, GLM 5.2
Sonnet not in the same ballpark of pricing (more expensive than Opus in many cases). Haiku has been basically abandoned.
E.g. for GeneBench Pro, it looks like you would always use GPT-5.6 Sol over Terra/Luna, its pareto optimal.
For Agents Last Exam, you would maybe want Luna, then Terra, then Luna, then Sol as you increasingly budget for tasks.
I feel that there may need to be a new auto mode in many of these cases. It selects the best model and thinking given a particular problem.
Feels like it's going to have to go that way eventually, because here we have about 20 different model and thinking levels you could use, and they're not obvious which ones are right for the given use case.
This is a model I could really see used inside applications, where Opus or Sonnet or GPT-5.5 are too expensive.
I would really like to see a strong Deepseek v4-Flash competitor, which ideally is something like Sonnet 4.6 performance at <$0.30 per token. This is missing from main US labs.
We could be much more flexible in our approach to things if we would un-ban things. For example after phase 1 trial or based on sufficient observational evidence, things can no longer be banned but have a higher standard for "insurance is now required to cover it".
Similar for vaccines, just give us the numbers clearly and upfront.
This bypasses regulators from having to make claims beyond “we reviewed the data and agree with these numbers and feel that this should not be banned.” I do think it would also help to separate something “not banned” and being “required to be covered by insurance” or “required for professions like the military”. I think trying to simplify things makes things worse, because this abstraction is not real.
I also like that the difference between low, medium, high, xhigh seems more spread, which is actually a good thing for people trying to tune applications. Running Sonnet 5 on low with the launch pricing makes this potentially a better fit than Haiku or open source models for some tasks. I don't think it will make sense at full price.
(To be clear: I do not like this new paradigm)
I suspect the problem is that they need to charge a lot to keep revenue numbers up, and they are more worried about cannibalizing themselves than others cannibalizing them.
I do think ground based centers will have better economics when they can be built though, and this addresses noise and water complaints which are the big 2 regional complaints.
It seems like lots of bottlenecks are getting solved quickly, except for maybe memory.
I know its not. Obviously Meta has been involved here a long time, but this is basically what Snapchat should probably have launched.
And these do seem cool, I would consider these for $299 even as a fun purchase.
The argument is that current full body scans often have false positives, and our treatment of false positives is bad including risky biopsies. Some have gone so far as to literally state early detection does not lead to better outcomes (simply not true - genuine early detection is very helpful but what they mean is it is outweighed at the population level by false positives).
The counter argument is that more information is always good but that you must learn to handle the noise, and we should focus on improving how we handle false positives. Including, but not limited to more frequent and abundant scans of various types.
The reason this is trending is because it both includes the argument and feels nice that someone changes their mind.
Personally, I think a lot of the issues here come down to the fact that we lie about the statistics instead of just show them. A test is neither positive or negative. It’s x% updated probability that you have something.
This process is an ongoing effort, with an upfront engineering commitment which depends entirely on the product, but can be months of work. But if you have your own backend, I would argue this hard works is made HARDER by implementing something like Salesforce/Fin, because you have to now pipe a bunch of data and structure over to them, which is a pain.
LLM models capable of doing this are a commodity, the UI for customers and support teams is pretty trivial, the database/backend is trivial.
Outside of some cases, if you have your own app, and you have a given support volume, build your own.
This is rarely discussed, and while I agree we should be spending non-zero effort on safety, stopping progress is not an option.
IMO Anthropic should just play the game at all the price tiers because it otherwise forces people to go elsewhere. I would probably pay for a "Proverb"/"Aphorism" class model that was worse than Deepseek at the same price just to stay in the ecosystem, if given the option.
(Note: I also see Google seem to make the same mistake, they actually do have competitive models in Gemma family but they don't make them available via the API. So there may be some reason for this.)